Literature DB >> 24133109

Surgical cost of care in Crohn's disease.

Deborah S Keller, Jeffry Katz, Sharon L Stein, Conor P Delaney.   

Abstract

UNLABELLED: The aim of the study was to evaluate the cost of surgical care and short-term outcomes of Crohn's disease(CD) in the era of laparoscopy and biologic therapy.
MATERIAL AND METHODS: Review of a prospective database identified CD patients that underwent surgical management. Patients were stratified into laparoscopic, open, and converted approaches. Main outcome measures were short-term patient outcomes and cost of care by approach.
RESULTS: 92 patients were analyzed- 63.1% laparoscopic, 32.6% open, 4.3% converted. The majority was elective (100% converted, 94.8% laparoscopic, 90% open) and segmental resections (75% converted, 70.7% laparoscopic, 43.3% open). Operative times were similar between laparoscopic and open (152 minutes and 138 minutes, respectively). More open patients required ICU care (20% versus 12.1% laparoscopic and 0% converted). The median LOS was 3 (1-25) days laparoscopic, 4 (1-29) open and 4 (3-8) converted. The laparoscopic complication rate was 15.5%, readmission rate 12.1%, and reoperation rate 8.6%. The mean total hospital cost was $9,702 laparoscopic, $10,782 open, and $13,293 for converted cases (US Dollars).
CONCLUSIONS: Laparoscopy is appropriate for most CD cases. When necessary to combine with open surgery, this results in efficient and effective patient outcomes and healthcare utilization. These results are important when weighing the cost of ongoing medical therapy versus surgical intervention.

Entities:  

Mesh:

Year:  2013        PMID: 24133109     DOI: 10.2478/pjs-2013-0079

Source DB:  PubMed          Journal:  Pol Przegl Chir        ISSN: 0032-373X


  3 in total

Review 1.  Laparoscopic surgery in the management of Crohn's disease.

Authors:  James Y Lim; Joseph Kim; Scott Q Nguyen
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

2.  A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease.

Authors:  Parambir S Dulai; Vipul Jairath; Neeraj Narula; Emily Wong; Gursimran S Kochhar; Jean-Frederic Colombel; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2021-08-01       Impact factor: 12.045

Review 3.  Minimally invasive surgery for inflammatory bowel disease.

Authors:  Jennifer Holder-Murray; Priscilla Marsicovetere; Stefan D Holubar
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.